Sherilyn Adcock
EVP Medical & Scientific Affairs Early Development
Worldwide Clinical Trials

Dr. Sherilyn Adcock, R.Ph., Ph.D. serves as Executive Vice President, Scientific Solutions at Worldwide Clinical Trials, LLC (Worldwide). Dr. Adcock has also served as the Chief Scientific Officer of Early Phase Drug Development and Senior Vice President of Early Phase Drug Development at Worldwide. Prior to joining Worldwide in 2001, Dr. Adcock had been the Senior Director of Clinical Site Operations for SCIREX Corporation in Austin, Texas.
In addition, she held posts as Vice President of the Clinical Research Center and Director of Business Development at Phoenix International Life Sciences, Director of Clinical Research and Business Development at HealthQuest Therapy and Research Institute, a Senior Project Director for the Biomedical Research Group and a Principal Investigator and Assistant Director of Project Management at Pharmaco International. She began her career as a Pharmacist and Clinical Instructor in Pharmacy and was the Pharmacy Services Supervisor at Mother Frances Hospital in Tyler, Texas. In addition to her licensure by the Texas State Board of Pharmacy, Dr. Adcock is certified in basic cardiac life support and sterile products preparation. She is a Member of the American Association of HealthCare Pharmacists, the Drug Information Association (DIA) and the American Association of Pharmaceutical Scientists (AAPS). Dr. Adcock earned her B.S. in Pharmacy, a M.S. in Health Science and a Ph.D. specializing in Community Health, all from the University of Texas at Austin.